Related Experiment Video
Updated: Jan 25, 2026
Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
Oncolytic Immunotherapy
Morgan L Hennessy1, Praveen K Bommareddy2, Genevieve Boland1
1Division of Surgical Oncology, Massachusetts General Hospital, 55 Fruit Street, Yawkey 7B, Boston, MA 02114, USA.
Abstract:
Oncolytic viruses are naturally occurring, or genetically engineered viruses that can be administered via intralesional injections or intravenously to induce cell death in tumor cells and activate antitumor immune responses. This review summarizes several oncolytic viruses in preclinical and clinical trials, describes challenges in clinical implementation, and important areas of future investigation.
Insights
Oncolytic viruses are viruses that destroy tumor cells and stimulate immune responses against cancer. This review covers their use in trials, challenges, and future directions.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Oncolytic viruses are viruses that selectively infect and kill cancer cells.
- They can also stimulate the body's immune system to attack tumors.
- These viruses can be naturally occurring or genetically engineered.
Purpose of the Study:
- To review the current status of oncolytic viruses in cancer treatment.
- To summarize key preclinical and clinical findings.
- To identify challenges and future research areas.
Main Methods:
- Literature review of preclinical and clinical studies on oncolytic viruses.
- Analysis of administration routes (intralesional, intravenous).
- Evaluation of efficacy and safety data.
Main Results:
- Several oncolytic viruses are in various stages of clinical trials.
- Evidence suggests potential for tumor cell lysis and immune activation.
- Challenges include delivery, immunogenicity, and resistance.
Conclusions:
- Oncolytic virus therapy shows promise in oncology.
- Further research is needed to overcome clinical implementation hurdles.
- Optimizing viral design and delivery is crucial for future success.
